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SUMMARY 
Staphylococcus aureus is the most frequent causative organism of infective endocarditis (IE) 
and is characterized by thrombus formation on a cardiac valve that can embolize to a distant 
site. Previously, we showed that S. aureus clumping factor A (ClfA) and fibronectin-binding 
protein A (FnBPA) can stimulate rapid platelet aggregation. In this study we investigate their 
relative roles in mediating aggregate formation under physiological shear conditions. Platelets 
failed to interact with immobilized wild-type S. aureus (Newman) at shear rates <500s-1 but 
rapidly formed an aggregate at shear rates >800s-1. Inactivation of the ClfA gene eliminated 
aggregate formation at any shear rate. Using surrogate hosts that do not interact with platelets 
bacteria over-expressing ClfA supported rapid aggregate formation under high shear with a 
similar profile to Newman while bacteria over-expressing FnBPA did not. Fibrinogen binding 
to ClfA was found to be essential for aggregate formation although fibrinogen-coated surfaces 
only allowed single–platelets to adhere under all shear conditions. Blockade of the platelet 
immunoglobulin receptor FcγRIIa inhibited aggregate formation. Thus, fibrinogen and IgG 
binding to ClfA is essential for aggregate formation under arterial shear conditions and may 
explain why S. aureus is the major cause of IE. 
 
Condensed abstract. Both Staphylococcus aureus clumping factor A (Clf A) and fibronectin-
binding protein A (Fnbp A) mediate rapid platelet aggregation. However, only Clf A can 
induce rapid aggregate formation under arterial shear conditions that is dependent on antibody 
and fibrinogen binding. The corresponding platelet receptors are GPIIb/IIIa and FcγRIIa. 
 
 
 
Infective endocarditis (IE) is characterized 
by the formation of platelet-bacteria 
thrombi on a heart valve which, if 
untreated, can lead to valve failure or the 
formation of infected emboli1. Infection of 
damaged or replacement valves is usually 
due to Streptococcus spp while infection of 
native valves is usually due to 
Staphylococcus aureus 2. While many 
species of bacteria have been reported to 
cause endocarditis the majority of cases are 
due to S. aureus 3. The reason for the 
dominance of S. aureus-mediated IE is not 
known. 
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The ability of bacteria to interact with 
platelets has been shown to be important in 
the pathogenesis of IE 1. Bacteria can 
adhere to platelets and induce platelet 
aggregation. However these are two 
separate properties and are often mediated 
by distinct surface proteins4. Animal 
studies have shown that the ability of S. 
aureus to adhere to platelets and the ability 
of S. sanguis to induce platelet aggregation 
are important in infective endocarditis5-8. 
 
The complex interplay between platelets 
and bacteria is still not completely 
understood 9. Successful colonization is 
likely to be the defining event leading to 
initiation of an infection1. Several different 
surface adhesins called microbial surface 
component reacting with adhesive matrix 
molecules (MSCRAMMs)10 promote 
adhesion to and activation of platelets 
including clumping factor ClfA and 
fibronectin-binding proteins A and B 
(FnBPA and FnBPB)12. Both ClfA and 
FnBP bind fibrinogen allowing an 
interaction with platelet GPIIb/IIIa that 
supports bacterial adhesion to platelets. In 
the presence of specific antibodies to the 
MSCRAMM, engagement of the platelet 
Fc receptor FcγRIIa occurs which 
stimulates platelet activation and 
subsequent aggregation11, 12. 
 
There are several major concerns with the 
studies of S. aureus-platelet interactions. 
Firstly, most previous studies have been 
carried out under static (adhesion) or non-
physiological stirring conditions 
(aggregation). Therefore, it is difficult to 
relate these studies to the disease process 
as cells in the vasculature experience a 
range of shear conditions. Some studies 
have been performed in vitro under shear 
to better characterize platelet-bacteria 
interactions under more physiological 
conditions. Studies using a cone and plate 
viscometer have shown that both protein A 
and ClfA are important in thrombus 
formation. However, extremely high shear 
levels were used13. A recent study showed 
a role for ClfA, SdrC, SdrD, SdrE and 
protein A in a parallel plate flow 
chamber14 An earlier study showed a role 
for antibody in thrombus formation under 
shear 15. 
 
Secondly, it may not be possible to 
investigate the interaction between S. 
aureus and platelets using an animal 
model. Several early studies suggest that 
platelets isolated from rabbits interact with 
S. aureus differently to platelets isolated 
from humans. For example, S. aureus-
induced aggregation of rabbit platelets was 
biphasic and was not inhibited by an RGD 
peptide that binds to GPIIb/IIIa16,17. This is 
in direct contrast to S. aureus-induced 
aggregation of human platelets which is 
monophasic and is inhibited by RGD 
peptides. Moreover, several studies have 
now highlighted the importance of the 
platelet Fc receptor, FcγRIIa, in platelet 
activation by S. aureus 11,12. Murine 
platelets do not express FcγRIIa18, 
suggesting that the mechanism of S. aureus 
induced platelet aggregation differs 
between human platelet and murine 
platelets.  
 
To address this problem we investigated 
the molecular mechanisms of S. aureus-
induced human platelet aggregate 
formation under venous and arterial shear, 
using a parallel flow chamber. We also 
investigate the relative roles of clumping 
factor A and fibronectin-binding proteins 
A in the interaction between platelets and 
immobilized S. aureus in a fluid shear 
environment and assess the role of plasma 
proteins in aggregate formation under both 
arterial and venous shear rates. We show 
that ClfA is expressed on the bacterial cell 
surface and mediates rapid aggregate 
formation under high shear in a process 
that requires both fibrinogen and anti-ClfA 
antibodies, while FnBPA does not play a 
role in thrombus formation.  
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Methods 
 
Materials 
Plasminogen-depleted human plasma 
fibrinogen and bovine serum albumin 
(BSA) were purchased from Calbiochem, 
Nottingham, UK. Purified pooled human 
IgG was obtained from Baxter, UK. 
Platelet αIIbβ3 antagonist, tirofiban, was 
purchased from Merck, UK. Platelet anti-
FcγRIIa antibody, IV.3 was a kind gift 
from Dr. J Kimkowsky, Medarex Inc. NJ, 
USA. Lipophilic dye, 3,3'-
dihexyloxacarbocyanine iodide (DiOC6) 
was purchased from Biosciences, Franklin 
Lakes, NJ, USA. Flow chambers were 
purchased from GlycoTech, Rockville, 
MD, USA. Glass cover slides were 
purchased from BioWorld, Atlanta, GA, 
USA. Bacterial growth media were 
purchased from Oxoid Ltd, Basingstoke, 
UK. All other reagents were purchased 
from Sigma, Poole, UK  
 
Bacterial strains and growth conditions 
S. aureus was grown in brain heart 
infusion (BHI) broth at 37ºC with shaking 
(200rpm) for 18hrs (stationary phase). S. 
aureus Newman defective in clumping 
factor A has been described elsewhere19. 
Lactococcus lactis was used to carry empty 
vector (pKS80) or for heterologous 
expression of the S. aureus surface protein 
ClfA (pKS80clfA+)20. L. lactis was 
routinely grown in M17 agar or statically 
in M17 broth incorporating 0.5% (w/v) 
glucose at 30ºC for 18 hrs21. S. aureus 
strain 8325-4 which lacks FnBPA and the 
plasmid containing the entire fnBPA gene 
have been described elsewhere22. 
Antibiotics were incorporated into the 
growth media where appropriate: 
erythromycin (5µg/ml) and ampicillin 
(100µg/ml). Bacteria were harvested and 
washed twice by centrifugation at 
15,000xg for 5 minutes. Washed bacteria 
were finally resuspended in phosphate 
buffered saline (PBS) and adjusted to an 
optical density of 1.4.  
 
Platelet preparation 
Peripheral blood was collected from 
healthy human adult volunteers after 
informed consent. Nine volumes of whole 
blood were collected into one volume of 
3.8% sodium citrate. Platelet-rich plasma 
(PRP) was prepared as previously 
described4. To prepare platelets free of 
plasma proteins, prostaglandin E1 (1µM) 
and apyrase (1U/ml) were added to PRP 
and centrifuged at 650xg for 10 minutes. 
The plasma was removed from the platelet 
pellet and resuspended in the same volume 
of JNL buffer (6mM dextrose, 130mM 
NaCl, 9mM NaCl2, 10mM Na citrate, 
10mM Tris base, 3mM KCL, 0.8 KH2PO4 
and 0.9mM MgCl2). These plasma-free 
platelets were resuspended in physiological 
buffer were added back to whole blood for 
some experiments. 
 
Preparation of flow chamber slides. 
A 1ml solution of either fibrinogen 
(20µg/ml) or S. aureus (109 bacterial cells) 
was applied to glass slides (75 x 25 mm) 
and allowed to attach overnight at 4ºC or 
for 2hrs at room temperature in a humidity 
chamber. Uniform bacterial coverage on 
glass slides was verified by crystal violet 
staining. Slides were washed 3 times in 
PBS buffer to remove any unbound 
bacteria or fibrinogen. Finally, the slides 
were blocked with 1% BSA for a further 1 
hour at 37ºC.  
 
L. lactis failed to adhere to the glass slides 
(probably due to its surface charge) 
therefore it was necessary to generate 
appropriate charges on both the glass slides 
and bacterial surface. Glass slides were 
submersed in 1% Triton-X 100 for 30 
minutes and washed in running tap water 
for a further 30 minutes. The slides were 
then sterilized using 95% EtOH and 
allowed air dry. To produce a covalently 
bound amino group on the glass surface 
the slides were submersed in freshly 
prepared 2% solution of 3-
aminopropyltriethoxysilane in dry acetone 
for 5 seconds. Finally, glass slides were 
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washed in distilled water (5 minutes x 2) 
and dried overnight at 42ºC. This method 
produces a surface covered in amino 
groups which will covalently bind to free 
aldehydes. Bacterial cells were centrifuged 
at 15,000xg. Pellets were resuspended in 
5mls 0.5% formaldehyde for 1hour at 
room temperature with occasional mixing. 
The suspension of bacterial cells was 
finally centrifuged at 15,000xg and the 
resultant pellet resuspended and adjusted 
to a final OD of 1.4 using PBS. This 
method creates a bacterial surface covered 
in free aldehydes capable of covalently 
binding to the amino groups on the silane 
treated slides. 
 
Epi-fluorescence digital microscopy 
Platelet interaction with immobilized 
protein or bacteria under various flow 
conditions was studied using a parallel 
flow chamber. Platelets were labeled in 
whole blood by direct incubation with the 
fluorescent lipophilic dye 3,3'-
dihexyloxacarbocyanine iodide (DiOC6). 
A syringe pump (Harvard Biosciences, 
MA, USA) was used to aspirate blood 
through the flow chamber. Platelet 
adhesion and aggregate formation was 
visualized using phase contrast and 
fluorescent imaging microscopy (63X oil 
immersion lens-Achroplan objective) 
through the flow chamber (GlycoTech, 
Rockville, MD, US) mounted on a Zeiss 
Axiovert-200 epi-fluorescence microscope 
(Carl Zeiss, Welwyn Garden City, UK). 
Images were taken at the same downstream 
location (from flow chamber entrance) in 
all experiments. Images were captured 
every second up to 300s by a liquid chilled 
Quantix-57 CCD camera (Photometrics 
Ltd, Tuscon, AZ, USA). Platelet adhesion 
and aggregate formation was analyzed 
using MetaMorph software (Universal 
Imaging Corp., Downingtown, PA, USA).  
 
Statistical Analysis 
Statistics were performed using InStat 
statistical software (GraphPad software, 
SD, USA). Data shown are the means plus 
or minus standard error of the mean (SEM) 
and comparisons between mean values 
were performed using the Student paired or 
unpaired t-test.  
 
RESULTS  
 
Aggregate formation on immobilized S. 
aureus strain Newman under shear 
conditions 
Using bright-field-imaging microscopy 
platelets (visualized as black cells) 
perfused under low shear conditions (50s-1) 
in plasma failed to interact with 
immobilized S. aureus Newman after 300 
seconds (fig 1a). At higher shear rates 
(>100s-1) cells are concentrated in the 
centre of the flow stream making 
interaction with the surface difficult, 
however, if whole blood is used the larger 
cells (red and white blood cells) are carried 
to the centre of the main stream of flow, 
leaving the smaller cells (platelets) in a 
better position to interact with immobilized 
bacteria on the glass slides. Platelets in 
whole blood stained with a lipophilic dye 
also failed to interact with immobilized S. 
aureus Newman when the shear rate was 
increased to 200s-1 or 500s-1 (data not 
shown).  
 
Increasing the shear rate to 800s-1 led to 
adhesion of platelets to immobilized S. 
aureus strain Newman. Platelet aggregates 
began to form (white areas) within 100 
seconds and became progressively larger 
as perfusion continued (fig 1b). After 300 
seconds aggregate formation covered 
almost the entire visible field of view 
(1±0.2% coverage at 50s-1 and 90±5% 
coverage at 800s-1, n=3, P<0.0001). 
Perfusing whole blood at 1500s-1 led to 
more rapid platelet deposition and 
aggregate formation than at 800s-1. Large 
platelet aggregates began to form at 100 
seconds leading to complete occlusion of 
the field of view by 200 seconds. After 250 
seconds the aggregate fragmented leaving 
behind the immobilized S. aureus 
Newman. With further perfusion of 
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platelets the process of aggregate 
formation began again on the remaining 
immobilized S. aureus Newman (fig 1b). 
Platelets perfused at 800s-1 failed to 
interact with S. aureus strain 8325-4 (fig 
1c, 90±5% coverage on Newman and 
0±0.0% coverage on 8325-4, n=3, 
P<0.0001). 
 
Aggregate formation on immobilized S. 
aureus strain Newman lacking ClfA 
expression  
The ability of the ClfA-containing strain 
Newman to induce platelet aggregation is 
in contrast to the lack of activity of strain 
8325-4 which does not contain ClfA and 
suggests a role for ClfA in the interaction 
with platelets. It also suggests that this 
protein may play a more dominant role in 
aggregate formation than FnBPA. To 
address this question we studied a ClfA 
mutant of S. aureus Newman (ClfA-). 
Platelets in whole blood perfused at 800s-1 
failed to interact with Newman ClfA- after 
300 seconds (fig 2b; 90±5% coverage on 
Newman ClfA+ and 2±1% coverage on 
Newman ClfA-, n=3, P<0.0001) or at the 
higher shear rate of 1500s-1 (data not 
shown). 
 
Aggregate formation on immobilized 
surrogate hosts over expressing ClfA or 
FnBPA 
To confirm the relative importance of ClfA 
in mediating aggregate formation under 
high shear both ClfA and FnBP A were 
separately over-expressed in surrogate 
hosts. Platelets perfused in whole blood 
failed to interact with fixed L. lactis at any 
shear rate tested (fig 3a). However, 
platelets perfused at 800s-1 time-
dependently adhered to fixed L. lactis 
expressing ClfA. After 100 seconds large 
platelet aggregates formed with eventual 
complete occlusion at 300 seconds (fig 3b) 
in a similar fashion to S. aureus Newman 
(0.5±0.1% coverage on L. lactis pKS80 
and 89±4% coverage on L. lactis ClfA+, 
n=3, P<0.0001,). In contrast, platelets 
perfused in whole blood at 800s-1 failed to 
interact with either S. aureus strain 8325-4 
(fig 3c) or S. aureus 8325-4 over 
expressing FnBPA (0±0.0% coverage on 
8325-4 FnBPA- and 1±0.2% coverage on 
FnBP+, n=3, NS). Comparative analysis by 
flow cytometry and western blot of S. 
aureus Newman and L. lactis cells 
expressing ClfA showed that L. lactis 
expressed similar levels of protein on their 
surface compared to S. aureus. 
Furthermore, western blot data 
demonstrated high levels of FnBPA in S. 
aureus strain 8325-4 (data not shown). 
 
Platelet adhesion to immobilized 
fibrinogen at high and low shear 
We next investigated the molecular 
mechanisms following ClfA-induced 
aggregate formation. Fibrinogen plays a 
major role in platelet aggregate formation, 
an important step in thrombus formation. 
To investigate if the platelet interaction 
with S. aureus was simply due to ClfA 
binding fibrinogen and presenting passing 
platelets with a thrombogenic surface, we 
immobilized purified fibrinogen and 
perfused platelets at both high and low 
shear. Under low shear conditions (150s-1) 
single platelets adhered to the immobilized 
fibrinogen in a time-dependent manner (fig 
4a). Increasing the shear rate to 800s-1 also 
led to the development of a monolayer of 
single platelets but no aggregate was 
formed even at 300 seconds (fig 4b). These 
results suggest that fibrinogen binding to 
ClfA is not sufficient to induce aggregate 
formation alone and that other plasma 
factors may play a role.  
 
Platelet activation following L. lactis ClfA 
- induced aggregate formation.  
To dissect the mechanisms leading to 
aggregate formation, whole blood was 
treated with aspirin (10µM) and perfused 
over immobilized L. lactis ClfA at 800s-1. 
Aggregate formation was strongly 
inhibited but single platelet adhesion 
occurred (fig 5c; 89±4% coverage with L. 
lactis ClfA and 7±1% coverage when 
treated with aspirin, n=3, P<0.0001). We 
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next assessed the importance of fibrinogen 
binding to platelets in initiating aggregate 
formation. Addition of the GPIIb/IIIa 
antagonist, tirofiban (0.5µM) to blood 
completely inhibited both aggregate 
formation and single platelet adhesion (fig 
5d; 89±4% coverage over L. lactis ClfA 
and 4±0.1% coverage in the presence of 
tirofiban, n=3, P<0.0001). These results 
suggest that GPIIb/IIIa and 
cyclooxygenase play an essential role in 
aggregate formation in this model system.  
 
Role of plasma proteins in S. aureus ClfA- 
induced aggregate formation.  
As platelets perfused under high shear 
(800s-1) are capable of interacting with 
immobilized L. lactis ClfA we set out to 
determine if plasma factors are involved in 
aggregate formation. Single platelet 
adhesion was observed when gel-filtered 
platelets were combined with washed red 
blood cells and perfused over immobilized 
L. lactis ClfA (fig 6a; 13±2% coverage in 
plasma-free platelets perfused over L. 
lactis ClfA and 89±4% coverage when 
plasma was included, n=3, P<0.001). 
Single platelet adhesion was also observed 
when antibody purified fibrinogen was 
also added (fig 6b, 89±4% coverage with 
plasma-rich platelets perfused over L. 
lactis ClfA and 9±0.2% coverage with 
plasma-free platelets supplemented with 
fibrinogen, n=3, P<0.002). No interaction 
was observed when pooled human IgG was 
added (fig 6c; 89±4% coverage with 
plasma-rich platelets perfused over L. 
lactis ClfA and 2±0.5% coverage with 
plasma-free platelets supplemented with 
IgG, n=3, P<0.0001). However, when 
washed blood cells were combined with 
fibrinogen and pooled human IgG time-
dependent aggregate formation (fig 6d) 
similar to that with whole blood was 
observed (89±4% coverage with plasma-
rich platelets perfused over L. lactis ClfA 
and 74±3% coverage with plasma-free 
platelets supplemented with fibrinogen and 
IgG, n=3, P=NS). When gel-filtered 
platelets were treated with the monoclonal 
antibody IV-3 aggregate formation was 
reduced to single platelet adhesion (fig 6e; 
89±4% coverage with plasma-rich platelets 
perfused over L. lactis ClfA and 8±2% 
coverage in the presence of IV.3, n=3, 
P<0.002). 
 
CONCLUSIONS 
 
S. aureus is the major cause of infective 
endocarditis and its ability to interact with 
platelets is essential for infection of heart 
valves23. Previous studies have shown that 
S. aureus expresses a number of proteins 
capable of activating platelets including 
ClfA, FnBPA, and FnBPB21,12. However 
the relative importance of the individual 
proteins is not clear. This is complicated 
by the fact that the roles of these proteins 
have been characterized with in vitro 
assays such as platelet aggregation which 
may not reflect the situation in vivo. 
 
Using a parallel plate chamber and a range 
of shear rates we investigated the ability of 
platelets to interact with immobilized S. 
aureus. The S. aureus strain Newman 
expressing ClfA induces platelet 
aggregation with a short lag time and 
strongly supports platelet adhesion under 
static conditions in the presence of 
fibrinogen. Under low shear conditions 
(venous shear) there is no evidence of 
platelet adhesion, presumably due to the 
weakness of the interaction which cannot 
support platelet attachment under shear 
stress. However, under high shear 
conditions (arterial shear) very strong 
adhesion occurred followed by rapid 
aggregate formation. This is an unique 
interaction in that other IE microorganisms 
such as S. sanguis24 or S. gordonii25 failed 
to interact at high shear however did 
interact at low shear. The aggregate 
formation is not solely due to platelets 
attaching to fibrinogen bound to the 
surface of immobilized bacteria as 
immobilized fibrinogen only supported 
single platelet adhesion without aggregate 
formation. This phenomenon of only 
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supporting platelet adhesion under high 
shear and not low shear is similar to that 
seen with vWf however; vWf is not 
involved in the interaction described here. 
Fibrinogen bound to ClfA will be subject 
to shear stress under flow conditions. The 
effect of shear will be to alter the 
conformation of fibrinogen. This activated 
conformation may be more effective at 
interacting with GPIIb/IIIa and is more 
likely to occur under high shear. So, under 
low shear bound fibrinogen can still 
interact with GPIIb/IIIa but this interaction 
is not strong enough to resist the shear 
stress preventing thrombus formation but 
at high shear the strength of the interaction 
is increased resulting in aggregate 
formation 
 
To characterize this interaction further, we 
examined the role of MSCRAMMs, the 
major platelet-interacting proteins of S. 
aureus. A ClfA defective mutant (ClfA-) of 
S. aureus Newman could still induce 
platelet aggregation (albeit with a longer 
lag time) and support platelet adhesion 
(data not shown). However, the mutant 
failed to support strong adhesion or 
aggregate formation under any shear 
condition. The essential role of ClfA in the 
interaction was confirmed by expression in 
the surrogate host L. lactis. L. lactis ClfA+ 
was as effective as Newman at inducing 
aggregation and adhesion under shear (data 
not shown). Thus, while there are a 
number of surface proteins on Newman 
capable of activating platelets, the only one 
that can trigger aggregate formation under 
shear is ClfA. 
 
Pawar et al demonstrated that protein A 
has the capability of binding to vWf under 
high shear but not low shear conditions13. 
This interaction acts as a bridging 
mechanism for crosslinking to platelet 
GPIb thereby initiating platelet adhesion. 
These experiments were carried out with S. 
aureus cells in suspension mixed with 
platelet-rich plasma and subjected to shear 
rates only found in severe pathological 
conditions (5000s-1). A more recent study 
demonstrated that L. lactis expressing 
protein A adhered time-dependently to 
immobilized von Willebrand factor at low 
shear rates (100s-1)26. Together these 
results suggest that the protein A – von 
Willebrand factor interaction may mediate 
the initial interaction leading to 
immobilization of bacteria at the site of 
injury but it is unlikely that protein A alone 
causes thrombus formation. We have 
shown that platelets fail to interact with 
immobilized L. lactis expressing protein A 
at any shear rate26 so it is more likely to act 
as a co-stimulator rather than a primary 
activator. 
 
Previous studies have shown that ClfA 
binds to fibrinogen which in turn binds to 
the platelet integrin GPIIb/IIIa. However, 
binding fibrinogen per se is not enough to 
induce platelet aggregation or lead to 
aggregate generation. When platelets were 
perfused over immobilized fibrinogen at 
either high or low shear, single platelet 
adhesion was observed but not aggregate 
formation. S. aureus is a common 
commensal of the human body and 
antibodies to surface proteins are present in 
the plasma of most if not all healthy 
individuals. We have shown previously 
that specific anti-ClfA antibodies are 
required for ClfA-induced platelet 
aggregation11 therefore we investigated 
their role in platelet interactions with 
bacteria under shear stress. Antibody 
binding to ClfA is itself not sufficient to 
induce aggregate formation. However, 
when fibrinogen and specific antibody 
together bound to ClfA, aggregate 
formation occurred. The role of antibody is 
to interact with the platelet Fc receptor 
FcγRIIa. A function-blocking monoclonal 
antibody directed against FcγRIIa inhibited 
the rapid aggregate formation. A 
requirement for antibody is in agreement 
with the previous study of Sjobring and co-
workers 15. 
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Several studies have recently identified the 
binding capabilities of S. aureus FnBP’s to 
human blood platelets12,27. Our results 
presented here do not disagree with these 
findings but have demonstrated that under 
high shear conditions FnBP’s do not have 
the ability to interact with or induce a 
aggregate formation. Similarly recent 
studies have suggested that FnBP’s play a 
role in binding to healthy resting 
endothelial cells28, however under shear 
this interaction does not take place29. 
Collectively these results suggest that the 
fibronectin-binding protein may have little 
or no role in aggregate formation but as IE 
is a complex disease they may still play a 
role in the pathology of the disease. It is 
also important to note that while there is 
high shear in the coronary vessels the 
situation is much more complex at the 
valve surface where turbulence is also 
likely to play a role. 
 
In summary the results from this study 
demonstrate, that the simultaneous binding 
of fibrinogen and antibody to ClfA, which 
interact with GPIIb/IIIa and FcγRIIa on the 
platelet surface, is essential for aggregate 
formation. This rapid aggregate formation 
is unique to ClfA and may explain the high 
incidence of S. aureus in infective 
endocarditis as it is a very powerful trigger 
of aggregate formation in the presence of 
anti-S. aureus antibody. ClfA may be a 
good candidate for a vaccine for patients at 
high risk of IE. However, it is essential that 
the antibodies generated would block the 
ClfA-fibrinogen interaction otherwise the 
presence of high levels of non-neutralizing 
antibody would likely exacerbate IE. 
FIGURE LEGENDS 
 
 
 
Figure 1. Platelet adhesion to immobilized 
S. aureus Newman under low and high 
shear conditions. A. S. aureus Newman 
was coated onto glass cover slips for 2 
hours at room temperature. Platelet-rich 
plasma was perfused over immobilized S. 
aureus Newman at 50s-1. For higher shear 
experiments platelets were labeled in 
whole blood by direct incubation with a 
fluorescent lipophilic dye 3,3'-
dihexyloxacarbocyanine iodide (DiOC6). 
Whole blood was perfused at 800 s-1 over 
immobilized S. aureus Newman (A) or 
8325-4 (B). Images were captured every 
second up to 300s. Images are 
representative fields taken from 1 of 3 
independent experiments that yielded 
similar results. 
 
Figure 2. Aggregate formation on 
immobilized S. aureus Newman. S. aureus 
Newman (A) and S. aureus Newman 
lacking expression of ClfA (ClfA-) (B) 
were coated onto glass cover slips for 2 
hours at room temperature. Platelets were 
labeled in whole blood by incubation with 
a fluorescent lipophilic dye 3,3'-
dihexyloxacarbocyanine iodide (DiOC6). 
Whole blood was perfused over 
immobilized bacteria at 800 s-1. Images 
were captured every second up to 300s. 
Images are representative fields taken from 
1 of 3 independent experiments that 
yielded similar results. 
 
Figure 3. Rapid aggregate formation on 
immobilized surrogate hosts over-
expressing ClfA and FnBPA under high 
shear conditions. L. lactis (A), L. lactis 
ClfA (B), S. aureus 8325-4 (C) and S. 
aureus 8325-4 FnBPA+ (D) were coated 
onto glass coverslips for 2 hours at room 
temperature. Platelets were labeled in 
whole blood by incubation with a 
fluorescent lipophilic dye 3,3'-
dihexyloxacarbocyanine iodide (DiOC6). 
Whole blood was perfused over bacteria at 
800 s-1. Images were captured every second 
up to 300s. Images are representative fields 
taken from 1 of 3 independent experiments 
that yielded similar results. 
 
Figure 4. Platelet adhesion to immobilized 
fibrinogen. Fibrinogen (20µg/ml) was 
coated on glass cover slips for 2 hours at 
room temperature. Platelets were labeled in 
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whole blood by incubation with a 
fluorescent lipophilic dye 3,3'-
dihexyloxacarbocyanine iodide (DiOC6) 
and perfused over immobilized fibrinogen 
at low (150s-1) and high (800s-1) shear. 
Platelet adhesion was visualized using 
epifluorescent digital imaging microscopy. 
Images were captured every second up to 
300s. Images are representative fields 
taken from 1 of 3 independent experiments 
that yielded similar results. 
 
Figure 5. Inhibition of ClfA-induced 
aggregate formation. L. lactis (A) and L. 
lactis ClfA (B, C & D) were coated onto 
glass coverslips for 2 hours at room 
temperature. Platelets were labeled in 
whole blood by incubation with a 
fluorescent lipophilic dye 3,3'-
dihexyloxacarbocyanine iodide (DiOC6). 
Whole blood was treated with  aspirin (C) 
or tirofiban (D) for 20 minutes. Drug 
treated whole blood was perfused over 
bacteria at 800 s-1. Images were captured 
every second up to 300s. Images are 
representative fields taken from 1 of 3 
independent experiments that yielded 
similar results. 
 
Figure 6. The role of plasma proteins in L. 
lactis ClfA- induced aggregate formation. 
L. lactis (A) and L. lactis ClfA (B, C, D, E) 
were coated onto glass coverslips for 2 
hours at room temperature. Platelets were 
separated from whole blood and plasma by 
centrifugation. Platelets were resuspended 
in physiological buffer and added back to 
whole blood. Platelets were labeled in 
whole blood by incubation with a 
fluorescent lipophilic dye 3,3'-
dihexyloxacarbocyanine iodide (DiOC6). 
Whole blood supplemented with either 
fibrinogen only (B), IgG only (C) or a 
combination of fibrinogen and IgG in the 
absence of (D) and presence of (E) the 
FcγRIIa inhibitor IV.3 was perfused over 
bacteria at 800 s-1. Images were captured 
every second up to 300s. Images are 
representative fields taken from 1 of 3 
independent experiments that yielded 
similar results. 
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